Cost-effectiveness Analysis in R Using a Multi-state Modeling Survival Analysis Framework: A Tutorial

被引:62
|
作者
Williams, Claire [1 ]
Lewsey, James D. [1 ]
Briggs, Andrew H. [1 ]
Mackay, Daniel F. [2 ]
机构
[1] Univ Glasgow, Inst Hlth & Wellbeing, Hlth Econ & Hlth Technol Assessment, 1 Lilybank Gardens, Glasgow G12 8RZ, Lanark, Scotland
[2] Univ Glasgow, Inst Hlth & Wellbeing, Publ Hlth, Glasgow, Lanark, Scotland
基金
英国医学研究理事会;
关键词
Markov models; cost-effectiveness analysis; probabilistic sensitivity analysis; survival analysis; COMPETING RISKS; CURVES;
D O I
10.1177/0272989X16651869
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This tutorial provides a step-by-step guide to performing cost-effectiveness analysis using a multi-state modeling approach. Alongside the tutorial, we provide easy-to-use functions in the statistics package R. We argue that this multi-state modeling approach using a package such as R has advantages over approaches where models are built in a spreadsheet package. In particular, using a syntax-based approach means there is a written record of what was done and the calculations are transparent. Reproducing the analysis is straightforward as the syntax just needs to be run again. The approach can be thought of as an alternative way to build a Markov decision-analytic model, which also has the option to use a state-arrival extended approach. In the state-arrival extended multistate model, a covariate that represents patients' history is included, allowing the Markov property to be tested. We illustrate the building of multi-state survival models, making predictions from the models and assessing fits. We then proceed to perform a cost-effectiveness analysis, including deterministic and probabilistic sensitivity analyses. Finally, we show how to create 2 common methods of visualizing the results-namely, cost-effectiveness planes and cost-effectiveness acceptability curves. The analysis is implemented entirely within R. It is based on adaptions to functions in the existing R package mstate to accommodate parametric multi-state modeling that facilitates extrapolation of survival curves.
引用
收藏
页码:340 / 352
页数:13
相关论文
共 50 条
  • [1] A COMPARISON OF R PACKAGES FOR PREDICTION AND SIMULATION OF MULTI-STATE MODELS FOR COST-EFFECTIVENESS ANALYSIS
    Incerti, D.
    Jansen, J. P.
    VALUE IN HEALTH, 2019, 22 : S322 - S322
  • [2] Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic Modeling
    Williams, Claire
    Lewsey, James D.
    Mackay, Daniel F.
    Briggs, Andrew H.
    MEDICAL DECISION MAKING, 2017, 37 (04) : 427 - 439
  • [3] An Introductory Tutorial on Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example
    Alarid-Escudero, Fernando
    Krijkamp, Eline
    Enns, Eva A.
    Yang, Alan
    Hunink, M. G. Myriam
    Pechlivanoglou, Petros
    Jalal, Hawre
    MEDICAL DECISION MAKING, 2023, 43 (01) : 3 - 20
  • [4] Distributional Cost-Effectiveness Analysis: A Tutorial
    Asaria, Miqdad
    Griffin, Susan
    Cookson, Richard
    MEDICAL DECISION MAKING, 2016, 36 (01) : 8 - 19
  • [5] A Tutorial on Time-Dependent Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example
    Alarid-Escudero, Fernando
    Krijkamp, Eline
    Enns, Eva A.
    Yang, Alan
    Hunink, M. G. Myriam
    Pechlivanoglou, Petros
    Jalal, Hawre
    MEDICAL DECISION MAKING, 2023, 43 (01) : 21 - 41
  • [6] A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper
    Mikyung Kelly Seo
    Mark Strong
    PharmacoEconomics, 2021, 39 : 1373 - 1381
  • [7] A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper
    Seo, Mikyung Kelly
    Strong, Mark
    PHARMACOECONOMICS, 2021, 39 (12) : 1373 - 1381
  • [8] Cost-Effectiveness Analysis and Decision Modelling: A Tutorial for Clinicians
    Gupta, Nidhi
    Verma, Rohan
    Dhiman, Radha K.
    Rajsekhar, Kavitha
    Prinja, Shankar
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (02) : 177 - 184
  • [9] Multi-state survival analysis in cost-effectiveness studies: the case of capecitabine versus docetaxel in metastatic breast cancer (mbc) for a private payer in Brazil
    Santos, E. A.
    Marques, R. M.
    VALUE IN HEALTH, 2007, 10 (06) : A341 - A341
  • [10] survHE: Survival Analysis for Health Economic Evaluation and Cost-Effectiveness Modeling
    Baio, Gianluca
    JOURNAL OF STATISTICAL SOFTWARE, 2020, 95 (14): : 1 - 47